Page last updated: 2024-08-25

3-deazaneplanocin and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated

3-deazaneplanocin has been researched along with Diffuse Lymphocytic Lymphoma, Poorly-Differentiated in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atadja, P; Balusu, R; Bhalla, K; Fiskus, W; Ganguly, S; Hembruff, SL; Marquez, VE; Mudunuru, U; Rao, R; Smith, JE; Sotomayor, E; Tao, J	1

Other Studies

1 other study(ies) available for 3-deazaneplanocin and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated

Article	Year
Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Nov-15, Volume: 18, Issue:22 Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Proliferation; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Expression; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Lymphoma, Mantle-Cell; Mice; Mice, Inbred NOD; Mice, SCID; Muscle Proteins; Neoplasm Proteins; Panobinostat; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Protein Binding; RNA Interference; SKP Cullin F-Box Protein Ligases; Transcription Factors; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2012

Article

Year

Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Nov-15, Volume: 18, Issue:22

Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Proliferation; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Expression; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Lymphoma, Mantle-Cell; Mice; Mice, Inbred NOD; Mice, SCID; Muscle Proteins; Neoplasm Proteins; Panobinostat; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Protein Binding; RNA Interference; SKP Cullin F-Box Protein Ligases; Transcription Factors; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2012